Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.43T
1-Year Return 25.4%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Quarter Return
+10.16%
1 Year Return
+25.4%
3 Year Return
+109.59%
5 Year Return
+197.61%
10 Year Return
+489.39%
AUM
$770B
AUM Growth
+$57.5B
Cap. Flow
+$9.58B
Cap. Flow %
1.24%
Top 10 Hldgs %
23.14%
Holding
4,968
New
70
Increased
3,379
Reduced
444
Closed
164

Sector Composition

1 Technology 26.15%
2 Healthcare 13.96%
3 Financials 12.56%
4 Consumer Discretionary 10.55%
5 Industrials 9.04%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
QBTS icon
4001
D-Wave Quantum
QBTS
$5.31B
$220K ﹤0.01%
331,323
+113,543
+52% +$75.4K
EAC
4002
DELISTED
Edify Acquisition Corp. Class A Common Stock
EAC
$219K ﹤0.01%
21,442
MEIP icon
4003
MEI Pharma
MEIP
$99.8M
$219K ﹤0.01%
47,836
AWH
4004
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$219K ﹤0.01%
39,851
HCNE
4005
DELISTED
Jaws Hurricane Acquisition Corp. Class A Common Stock
HCNE
$218K ﹤0.01%
21,452
NCSM icon
4006
NCS Multistage Holdings
NCSM
$117M
$217K ﹤0.01%
9,173
+136
+2% +$3.22K
GLTO icon
4007
Galecto
GLTO
$4.03M
$217K ﹤0.01%
4,358
CYT
4008
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$217K ﹤0.01%
119,032
+1,900
+2% +$3.46K
CTHR
4009
DELISTED
Charles & Colvard Ltd
CTHR
$217K ﹤0.01%
23,294
INUV icon
4010
Inuvo
INUV
$51.5M
$217K ﹤0.01%
74,242
IMPL
4011
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$216K ﹤0.01%
154,390
+152
+0.1% +$213
IRIX icon
4012
IRIDEX
IRIX
$23.8M
$216K ﹤0.01%
103,702
FKWL icon
4013
Franklin Wireless
FKWL
$47.8M
$216K ﹤0.01%
43,309
XPL icon
4014
Solitario Resources
XPL
$78.5M
$215K ﹤0.01%
325,150
QNCX icon
4015
Quince Therapeutics
QNCX
$86.5M
$214K ﹤0.01%
137,086
SOPH icon
4016
SOPHiA GENETICS
SOPH
$230M
$214K ﹤0.01%
42,966
+22,285
+108% +$111K
ATAI icon
4017
ATAI Life Sciences
ATAI
$975M
$212K ﹤0.01%
117,226
VECT
4018
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$212K ﹤0.01%
24,647
+1,593
+7% +$13.7K
ATAT icon
4019
Atour Lifestyle Holdings
ATAT
$5.52B
$212K ﹤0.01%
+8,087
New +$212K
POAI icon
4020
Predictive Oncology
POAI
$10.3M
$211K ﹤0.01%
32,301
AHRN
4021
DELISTED
Ahren Acquisition Corp. Class A Ordinary Shares
AHRN
$211K ﹤0.01%
20,270
TCRX icon
4022
TScan Therapeutics
TCRX
$106M
$211K ﹤0.01%
100,442
SCPX
4023
DELISTED
Scorpius Holdings, Inc.
SCPX
$211K ﹤0.01%
60
NGNE icon
4024
Neurogene
NGNE
$274M
$211K ﹤0.01%
15,053
FATP
4025
DELISTED
Fat Projects Acquisition Corp Class A Ordinary Share
FATP
$211K ﹤0.01%
20,151